The effectiveness of photodynamic therapy is limited by the lack of oxygen in solid cancers. Now, EU-funded researchers have developed drug delivery nano-carriers to bring oxygen to the tumour site. This strategy could improve the effectiveness of this photodynamic therapy and help to save the lives of citizens affected by cancer.
Cancer and neglected tropical diseases impact millions of people every year. By identifying compounds that specifically target affected cells, EU-funded researchers have opened the door to potential new treatments. These medicines could save lives and benefit citizens both in Europe and around the world.
While researchers were busy developing a handheld device to rapidly detect biomarkers to guide the therapy in lung cancer, the pandemic struck. Realising their device could be adapted to test for coronavirus, researchers refocused their work. The result is the market’s smallest portable PCR device.
Schistosomiasis is a parasitic disease, particularly dangerous to young children. With no child-safe method for treating it, millions of kids are left untreated and susceptible to anaemia, stunted growth, and impaired cognitive development. The European and Developing Countries Clinical Trials Partnership (EDCTP) supported the research that aims to change this by providing equitable access to an effective and safe paediatric treatment for the disease.
Changes to the sugars attached to proteins have been linked with a range of human diseases, but the tools needed to detect this phenomenon have been lacking. The EU-funded GLYCOSURF project developed a new test that can detect these subtle alterations. The technique provides a robust and reliable way to provide early diagnoses.
While the incidence of Alzheimer’s disease continues to grow at an alarming rate, advances in treatment and prevention have stalled. The EU-industry funded ADAPTED project worked to better understand how the presence of a specific gene significantly increases the risk of disease. This research could open the door to new treatment for patients.
Understanding how the brain regulates bodily functions is critical for tackling metabolic disorders and neurodegenerative diseases. The EU-funded WATCH project is shedding light on the molecular mechanisms that underpin this process. The work supports novel therapies that could benefit citizens affected by Alzheimer’s disease, diabetes and COVID-19.
Identifying the specific genetic mutations that cause cancer has always been a challenge. The EU-funded NONCODRIVERS project offers a solution with a pioneering approach that applies machine learning based modelling to tumour data. This could lead to more personalised therapies that save the lives of thousands of citizens every year.
Materials used in medical implants such as pacemakers and insulin pumps can be hazardous to the body. The EU-funded BISON project seeks an alternative in self-assembling peptide building blocks. These biological electronics offer citizens safer implants that could be powered by the body itself.
Millions of people suffer from brain diseases. To better understand what happens in the brains of these patients, the EU-funded RobustSynapses project focused on synapses, where many brain conditions often first develop. By identifying key things that can go wrong, the project team has opened the door to potential new targets for life-saving treatments that would benefit everyone.
